PJHRX
PGIM Jennison Health Sciences Fund
Prudential Sector Funds, Inc.
Expense ratio1
1.48%
Net assets2
$1.46B
Holdings2
51
Category
US Equity
2025 return3
18.90%

Investment objective & strategy

As of Jan. 28, 2026 · prospectus

Objective. The investment objective of the Fund is long-term capital appreciation .

Strategy. The Fund seeks investments whose prices will increase over time. The Fund normally invests at least 80% of its investable assets in equity and equity-related securities of health sciences companies, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the Health Care sector. The group of industries in which the Fund concentrates its investments is known as its sector. The term investable assets refers to the Fund's net assets plus any borrowings for investment purposes. The Fund's investable assets will be less than its total assets to the extent that it has borrowed money for … The Fund seeks investments whose prices will increase over time. The Fund normally invests at least 80% of its investable assets in equity and equity-related securities of health sciences companies, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the Health Care sector. The group of industries in which the Fund concentrates its investments is known as its sector. The term investable assets refers to the Fund's net assets plus any borrowings for investment purposes. The Fund's investable assets will be less than its total assets to the extent that it has borrowed money for non-investment purposes, such as to meet anticipated redemptions. The Fund invests in securities of issuers among a number of different countries throughout the world, one of which is the United States. The Fund has no limit on the amount of assets that must be invested in each country. However, the Funds investments in the securities of non-U.S. issuers, which are referred to as foreign securities and includes stocks and other equity-related securities, is limited to 35% of the Fund's total assets. The Fund participates in the initial public offering (IPO) market. Equity and equity-related securities in which the Fund primarily invests are common stocks, nonconvertible preferred stocks and convertible securities. The Fund holds those equity and equity-related securities in which the portfolio managers have a high level of conviction for outperformance in the intermediate and long term and believe have limited downside potential in the short term. The portfolio managers use fundamental and quantitative analyses to select individual securities.

Top holdings

As of Feb. 27, 2026 · N-PORT
SecurityTickerValue% of fund
LILLY ELI and CO $244.65M 16.77%
(PIPA070) PGIM Core Government Money Market Fund $112.60M 7.72%
MERCK & CO $87.78M 6.02%
GILEAD SCIENCES INC $63.72M 4.37%
UNITEDHEALTH GRP $62.81M 4.31%
VERTEX PHARMACEUTICALS INC $51.87M 3.56%
CVS HEALTH CORP $47.73M 3.27%
LONZA GROUP -REG $45.68M 3.13%
ARGENX SE SPONSORED ADR $45.28M 3.10%
REGENERON PHARMACEUTICALS INC $44.81M 3.07%
View all holdings →

Allocation by sector

As of February 27, 2026 · N-PORT
View portfolio breakdown →

Portfolio moves

Nov 28, 2025 → Feb 27, 2026
Opened
17
Exited
17
Increased
10
Decreased
14
Unchanged
10

How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.

View portfolio moves →

Similar funds

Funds whose portfolios most overlap this one, by weight
FundOverlapNet exp.
HARTFORD HEALTHCARE HLS FUND · HIAHX, HBGHX 44% 0.93%
EQ/T.Rowe Price Health Sciences Portfolio 43% 0.95%
THE HARTFORD HEALTHCARE FUND · HGHAX, HGHCX, HGHYX, HGHIX, HGHRX, HGHSX, HGHTX, HGHFX, HGHVX 43% 0.94%
View all similar funds →

Advisers

As of November 30, 2025 · N-CEN
FirmRole
PGIM INVESTMENTS LLC Adviser
Jennison Associates LLC Sub-adviser

Footnotes

  1. Expense ratio as of January 28, 2026, from the fund's prospectus.
  2. Net assets and holdings count as of February 27, 2026, from the fund's N-PORT filing.
  3. Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.